BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 44 filers reported holding BIOXCEL THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $37,292 | -37.5% | 13,224 | -34.6% | 0.00% | – |
| Q4 2023 | $59,661 | +11.1% | 20,224 | -4.7% | 0.00% | – |
| Q3 2023 | $53,697 | -81.0% | 21,224 | +226.7% | 0.00% | -100.0% |
| Q3 2020 | $282,000 | +15.6% | 6,497 | -40.5% | 0.00% | 0.0% |
| Q1 2020 | $244,000 | +12.4% | 10,914 | -26.5% | 0.00% | 0.0% |
| Q4 2019 | $217,000 | +24.0% | 14,850 | -7.2% | 0.00% | 0.0% |
| Q2 2019 | $175,000 | -42.1% | 16,000 | -47.6% | 0.00% | 0.0% |
| Q1 2019 | $302,000 | +196.1% | 30,550 | +128.8% | 0.00% | – |
| Q3 2018 | $102,000 | – | 13,350 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 430,000 | $19,866,000 | 1.70% |
| APIS CAPITAL ADVISORS, LLC | 20,000 | $924,000 | 0.89% |
| Avidity Partners Management LP | 547,000 | $25,271,000 | 0.82% |
| Knoll Capital Management, LLC | 20,000 | $924,000 | 0.63% |
| Artemis Investment Management LLP | 1,013,448 | $46,839,000 | 0.49% |
| AlphaCentric Advisors LLC | 25,000 | $1,155,000 | 0.48% |
| First Light Asset Management, LLC | 94,202 | $4,352,000 | 0.32% |
| Ikarian Capital, LLC | 150,000 | $6,930,000 | 0.31% |
| Longitude (Cayman) Ltd. | 8,000 | $370,000 | 0.18% |
| AllSquare Wealth Management LLC | 5,490 | $254,000 | 0.17% |